These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23016238)

  • 1. [Glucose control is a strategy for cardiovascular prevention].
    Nilsson PM; Leósdóttir M; Attvall S
    Lakartidningen; 2012 Sep 5-11; 109(36):1549-51. PubMed ID: 23016238
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensified glucose control in type 2 diabetes--whose agenda?
    Yudkin JS; Richter B; Gale EA
    Lancet; 2011 Apr; 377(9773):1220-2. PubMed ID: 21093903
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetes. Paradoxical effects of tightly controlled blood sugar.
    Taubes G
    Science; 2008 Oct; 322(5900):365-7. PubMed ID: 18927369
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current methods of glucose metabolism control in diabetes mellitus].
    Scarpitta AM; Sinagra D
    Recenti Prog Med; 2003 Jan; 94(1):31-40. PubMed ID: 12632998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of glycemic control in diabetes in the CVOT era.
    Einhorn D
    J Diabetes; 2020 Jan; 12(1):4. PubMed ID: 31746129
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intensive glucose control in type 2 diabetes is beneficial].
    Nilsson PM; Attvall S
    Lakartidningen; 2009 Sep 2-8; 106(36):2198. PubMed ID: 19817174
    [No Abstract]   [Full Text] [Related]  

  • 7. HgbA1c and glucose control: we cannot play it straight with patients.
    Hoogwerf BJ
    J Lab Clin Med; 2006 Jan; 147(1):5-6. PubMed ID: 16442999
    [No Abstract]   [Full Text] [Related]  

  • 8. How tight is too tight?
    Greiver M
    Can Fam Physician; 2009 Nov; 55(11):1066-7. PubMed ID: 19910589
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for diabetes in patients with cardiovascular disease: HbA1c trumps oral glucose tolerance testing.
    Sattar N; Preiss D
    Lancet Diabetes Endocrinol; 2016 Jul; 4(7):560-2. PubMed ID: 27039357
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vascular complications of diabetes: is there a glycemic threshold?].
    Isnard F; Eschwège E
    Rev Prat; 2001 Oct; 51(16):1759-64. PubMed ID: 11795118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)].
    Sato A
    Rinsho Byori; 2014 Jan; 62(1):45-52. PubMed ID: 24724426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is HbA1c 40 mmol/mol a sign of good diabetes care?].
    Ludvigsson J
    Lakartidningen; 2013 May 7-21; 110(19-20):928-9. PubMed ID: 23745496
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute blood sugar peaks endanger blood vessels: the postprandial situation to be controlled better].
    MMW Fortschr Med; 2006 Jun; 148(26):57. PubMed ID: 16875385
    [No Abstract]   [Full Text] [Related]  

  • 14. Glycated hemoglobin A1c-based adjusted glycemic variables in patients with diabetes presenting with acute exacerbation of chronic obstructive pulmonary disease.
    Yang CJ; Liao WI; Tang ZC; Wang JC; Lee CH; Chang WC; Hsu CW; Tang SE; Tsai SH
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1923-1932. PubMed ID: 28740373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic control and CAD risk: a heretical thought.
    Orchard TJ
    Diabetes Care; 1999 Jul; 22(7):1220. PubMed ID: 10388997
    [No Abstract]   [Full Text] [Related]  

  • 16. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study.
    Meigs JB; Nathan DM; D'Agostino RB; Wilson PW;
    Diabetes Care; 2002 Oct; 25(10):1845-50. PubMed ID: 12351489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycated hemoglobin as a marker of cardiovascular risk.
    Khaw KT; Wareham N
    Curr Opin Lipidol; 2006 Dec; 17(6):637-43. PubMed ID: 17095908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Postprandial glycemia in diabetes patients: assessing this indicator].
    Letonturier P
    Presse Med; 2006 Dec; 35(12 Pt 1):1855-6. PubMed ID: 17205659
    [No Abstract]   [Full Text] [Related]  

  • 19. Why are we doing cardiovascular outcome trials in type 2 diabetes?
    Menon V; Aggarwal B
    Cleve Clin J Med; 2014 Nov; 81(11):665-71. PubMed ID: 25368216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the usefulness of HbA1 as an index of the degree of control of diabetes mellitus.
    Fujita S
    Osaka City Med J; 1982; 28(2):99-113. PubMed ID: 7187017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.